Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Advancing Personalized Treatment in Pediatric Oncology Through Functional Precision Medicine

NCT05857969 is registered in ClinicalTrials.gov with Florida International University as lead sponsor.

NCT NCT05857969
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05857969 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Advancing Personalized Treatment in Pediatric Oncology Through Functional Precision Medicine
Lead sponsor
Florida International University
Phase
Phase 1
Overall status
Recruiting
Start date
February 22, 2023
Completion date
December 31, 2028
Enrollment
65 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent childhood acute lymphoblastic leukemia, recurrent childhood acute myeloid leukemia, recurrent childhood brain tumor, recurrent childhood brainstem glioma, recurrent childhood ependymoma, recurrent childhood gliosarcoma, recurrent childhood large cell lymphoma, recurrent childhood lymphoblastic lymphoma, recurrent childhood malignant neoplasm, recurrent childhood malignant solid neoplasm, recurrent childhood rhabdomyosarcoma, recurrent childhood soft tissue sarcoma, refractory childhood acute lymphoblastic leukemia, refractory childhood hodgkin lymphoma, refractory childhood malignant germ cell neoplasm, refractory childhood malignant neoplasm, refractory childhood malignant solid neoplasm, refractory chronic myelogenous leukemia, bcr-abl1 positive